Breaking News Instant updates and real-time market news.

CMCSA

Comcast

$43.17

0.82 (1.94%)

, AEO

American Eagle

$15.40

0.63 (4.27%)

19:34
08/18/19
08/18
19:34
08/18/19
19:34

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. President Donald Trump said on Sunday that he did not want the U.S. to do business with China's Huawei even as the administration weighs whether to extend a grace period for the company, according to Reuters. He said there were small parts of Huawei's business that could be exempted from a broader ban, but that it would be "very complicated." This follows earlier reports saying that the Trump administration was preparing to extend the length of a license that has enabled Huawei to continue working with U.S. customers despite national-security concerns that landed the telecom company on an export blacklist earlier this year. 2. The Centers for Disease Control and Prevention is investigating a "cluster" of lung illnesses linked to e-cigarette use after such cases were reported in 14 states, Reuters' April Joyner reported. Since June 28, states have reported 94 possible cases of severe lung illness tied to vaping, with 30 occurring in Wisconsin, the author noted, citing a CDC statement. The CDC said there was no evidence that an infectious disease was behind the illness but that more information was needed to determine whether they were caused by e-cigarette use. Juul, in which Altria Group (MO) has a 35% stake, is the dominant e-cigarette maker in the U.S., the publication added. 3. American Eagle's (AEO) outlook is more enticing than most investors realize, despite trade war that could still clip the wings of the apparel and accessories retailer, Leslie Norton wrote in this week's edition of Barron's. In a retail environment littered with failures, the company has been gaining market share, and hiding in American Eagle is one of the nation's fastest growing retailers, Aerie, the author noted. 4. Comcast (CMCSA) subsidiary Universal's "Good Boys" won the U.S. box office with a $21M debut from 3,204 theaters. This was the biggest opening for an original comedy in 2019 and the second-biggest of any comedy this year behind "Madea's Family Funeral." "Good Boys" received a B+ CinemaScore and 80% on Rotten Tomatoes. 5. Grocery Outlet (GO), Royal Dutch Shell (RDS.B), BP (BP), and Exxon Mobil (XOM) saw positive mentions in this week's edition of Barron's, while Myriad Genetics (MYGN) was mentioned cautiously.

CMCSA

Comcast

$43.17

0.82 (1.94%)

AEO

American Eagle

$15.40

0.63 (4.27%)

MO

Altria Group

$46.48

1 (2.20%)

CMCSK

Comcast

$0.00

(0.00%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

  • 27

    Aug

  • 04

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Oct

  • 13

    Nov

CMCSA Comcast
$43.17

0.82 (1.94%)

07/29/19
FBCO
07/29/19
NO CHANGE
FBCO
Credit Suisse sees virtually no impact for AT&T, Verizon from Dish near-term
Following the Justice Department's settlement with T-Mobile (TMUS) and Sprint (S), Credit Suisse analyst Douglas Mitchelson notes that for Altice USA (ATUS), the settlement requires mobile virtual network operator contracts to be extended through at least 7 years post closing, which he views as a "significant positive" for Altice. For cable broadly, Dish (DISH) would represent an "intriguing option" for entry into the wireless business longer-term if CEO decided to sell the company, he contends. The analyst would expect that Comcast (CMCSA) and Charter (CHTR) would wait until the point where wireless pricing and valuations are thought to have bottomed. For AT&T (T) and Verizon (VZ), Mitchelson sees virtually no impact from Dish the next few years as the company will be just focused on scaling marketing of its T-Mobile MVNO while building its wireless network. Longer-term, while Dish might be in a position to deflate wireless pricing, AT&T and Verizon should still have superior coverage, network density, backhaul, scale, and quality of service, he adds.
08/14/19
MACQ
08/14/19
DOWNGRADE
Target $31
MACQ
Neutral
Viacom downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Tim Nollen downgraded Viacom (VIAB) to Neutral from Outperform and keeps a Neutral rating on CBS (CBS) shares after the two companies announced a merger deal with no premium for Viacom following "3 years of on again/off again merger discussions amidst wrenching change in the industry." While he believes the deal's strategic positives outweigh the risks, Nollen said integration might not be easy and that ViacomCBS will still be "small-ish" compared with competitors Comcast (CMCSA) and Disney (DIS). He lowered his price target on Viacom shares to $31 from $37 and cut his price target on CBS shares to $53 from $55.
07/10/19
07/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comcast (CMCSA) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Brett Feldman saying he estimates Comcast will sustain "strong growth" over next three years with annual earnings growth of 11%, free cash flow per share of 12% and dividends of 15%, driven by "healthy fundamentals across its key businesses." 2. Total (TOT) upgraded to Outperform from Neutral at Credit Suisse with analyst Thomas Adolff saying he believes the company's Strategy Day in September will serve as a catalyst. 3. DMC Global (BOOM) upgraded to Buy from Neutral at Sidoti. 4. Core Laboratories (CLB) upgraded to Buy from Neutral at BofA/Merrill with analyst Chase Mulvehill saying he sees the stock being set to reverse its outperformance after having fallen 10% year-to-date. 5. HCA Healthcare (HCA) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Tanal saying he has a "greater appreciation for the resiliency" of the economic model of certain acute hospitals, notably HCA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/19
OTRG
08/01/19
NO CHANGE
OTRG
Broadcast and cable upfront pricing higher than expected, says OTR Global
OTR Global said its checks with U.S. media buyers and ad executives indicated that broadcast and cable networks increased upfront ad unit pricing higher than buyers expected. 2019 upfront prices were up 7%-10% year-over-year for broadcast and up 6%-9% year-over year for cable, exceeding sources' expectations of flat or slightly higher pricing, the firm noted, citing its checks.
AEO American Eagle
$15.40

0.63 (4.27%)

05/09/19
05/09/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Market Perform from Outperform at BMO Capital with analyst Ambrish Srivastava saying semi stocks do not do well in a decelerating gross margin environment, particularly when the bottom in margin is around two years away. 2. Camping World (CWH) downgraded to Underperform from Neutral at BofA/Merrill with analyst John Lavallo stating the company's outlook for 2019 seems "optimistic" following the company's "challenging" Q1 results. 3. Office Depot (ODP) double downgraded to Underperform from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying the company's Q1 report reduced her confidence in a near-term turnaround and she now believes Office Depot's guidance for the rest of the year may be too optimistic. 4. American Eagle (AEO) downgraded to Neutral from Outperform at Wedbush with analyst Jen Redding saying she believes that shares will continue to trade near 52-week lows for the foreseeable future. 5. Stamps.com (STMP) downgraded to Hold from Buy at Craig-Hallum with analyst George Sutton endorsing the company's long-term move to shift away from USPS exclusivity, but noting that it is a slower, more complicated process than he appreciated. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/19
JEFF
06/27/19
NO CHANGE
JEFF
Jefferies reiterates Buys on Guess, American Eagle after female survey
After surveying 600 female consumers to analyze changes in brand momentum, Jefferies analyst Janine Stichter reiterates Buy ratings on both Guess (GES) and American Eagle (AEO). Results are favorable for Guess, which is seeing an increase in brand awareness and improved purchasing intent, Stichter tells investors in a research note. For American Eagle, investments in the store experience are translating into improved customer satisfaction, while Aerie also continues to score well across all key metrics, adds the analyst.
06/06/19
WEDB
06/06/19
NO CHANGE
Target $20
WEDB
Neutral
American Eagle price target lowered to $20 from $25 at Wedbush
Wedbush analyst Jen Redding lowered her price target for American Eagle to $20 from $25, while reiterating a Neutral rating on the shares. Although Redding continues to remain bullish on American Eagle over the long-term, she now has less conviction in runway for shares in what she views as an increasingly volatile retail environment, until investor visibility into a U.S.-China trade settlement improves.
08/16/19
SBSH
08/16/19
NO CHANGE
SBSH
American Eagle and Abercrombie & Fitch should merge, says Citi
Citi analyst Paul Lejuez looked across his Retail universe to consider "possible winning combinations that make sense in this environment." One deal stood out, and that's American Eagle (AEO) and Abercrombie & Fitch (ANF) combining, Lejuez tells investors in a research note. It makes sense for both companies "to wed, creating a teen powerhouse," says the analyst.
MO Altria Group
$46.48

1 (2.20%)

08/09/19
WELS
08/09/19
NO CHANGE
WELS
Outperform
Altria has wide, defensible moat, says Wells Fargo
After conducting an in-depth review of the total U.S. nicotine market, Wells Fargo analyst Bonnie Herzog reiterated her Outperform rating on Altria Group shares, stating that her analysis highlights that growth is accelerating and confirms that Altria and Marlboro have "a wide and defensible competitive moat." While management's recently conveyed incrementally more negative outlook for cigarette industry volumes was interpreted by some as a possible warning that the company's long-term pricing and earnings model may be at risk, she disagrees with that view, Herzog tells investors. The analyst, who thinks the market "has again overreacted," sees a nice entry point into Altria shares for long-term investors.
07/16/19
WELS
07/16/19
NO CHANGE
WELS
Wells says Nielsen restatement could be positive for Monster, tobacco stocks
Wells Fargo analyst Bonnie Herzog noted that Nielsen (NLSN) just announced that it will restate data to address serious issues with its calculation methodology in the convenience store channel related to projections it applied to independent c-stores. The restated data, to be released on August 20, is expected to improve cigarette and energy drink trends and she views this as a positive for tobacco stocks and Monster Beverage (MNST). Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM).
08/13/19
PIPR
08/13/19
INITIATION
Target $18
PIPR
Overweight
Piper sees 'strong' sales growth for Cronos, starts with Overweight rating
Piper Jaffray analyst Michael Lavery last night initiated coverage of Cronos Group (CRON) with an Overweight rating and $18 price target. The analyst expects "strong" sales growth from Cronos, driven by "sustainable category momentum." The company's partnership with Altria (MO) provides important capital and access into 230,000 US retail outlets, as well as regulatory and vapor product expertise, Lavery tells investors in a research note. He expects Cronos to have "modest" near-term revenues from Canadian cannabis production, but believes it has "significant" potential growth opportunities with CBD products in the U.S.
07/12/19
07/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Buy from Neutral at Goldman Sachs with analyst Judy Hong saying the valuations in the tobacco sector are trading at a 10-year trough in spite of the "more accommodating" macro backdrop for Consumer Staples that includes a late cycle and lower yields. 2. Focus Financial (FOCS) upgraded to Outperform from Market Perform at Keefe Bruyette. 3. Deutsche Bank (DB) upgraded to Neutral from Sell at UBS. 4. Morgan Stanley (MS) upgraded to Buy from Neutral at Citi. 5. Snap (SNAP) upgraded to Buy from Neutral at Goldman Sachs with analyst Heath Terry saying the company's new Android app, the launch of Snap Games, and new viral lenses should accelerator user growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CMCSK Comcast
$0.00

(0.00%)

02/11/19
KEYB
02/11/19
NO CHANGE
Target $216
KEYB
Overweight
Workday price target raised to $216 from $179 at KeyBanc
KeyBanc analyst Brent Bracelin raised his price target for Workday (WDAY) to $216 from $179 on improving cloud growth prospects. The analyst notes that analysis of Key First Look Data: Jobs has exposed an unannounced F50 HCM win at UPS (UPS) that began hiring for the global HR transformation team in January. The data also exposed unannounced F100 HCM wins at Comcast (CMCSA; CMCSK), CapitalOne (COF), and Centene (CNC), although job dates suggest these deals may have closed in the October quarter. The January data also exposed a new cloud financials win at Adecco (AHEXY), Bracelin adds. The analyst reiterates an Overweight rating on Workday's shares.
12/07/18
WOLF
12/07/18
INITIATION
Target $48
WOLF
Outperform
Comcast Comcast initiated with an Outperform at Wolfe Research
Wolfe Research initiated Comcast with an Outperform rating and $48 price target.
GO Grocery Outlet
$46.55

2.81 (6.42%)

08/14/19
JEFF
08/14/19
NO CHANGE
Target $50
JEFF
Buy
Grocery Outlet price target raised to $50 from $41 at Jefferies
Jefferies analyst Randal Konik raised his price target for Grocery Outlet to $50 from $41 saying the company's Q2 results illustrated its "unique" qualities. Grocery Outlet offers "predictable and stable" fundamentals, a "topnotch" leadership team, and scalable model, Konik tells investors in a post-earnings research note titled "WOW! 2Q Shows This Unicorn's Growth & Predictable Fundies: Reit. Buy, PT to $50." He believes Grocery Outlet has created a "defendable moat."
07/15/19
07/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Slack Technologies (WORK) initiated with an Outperform at William Blair, an Overweight at Barclays, and a Buy at Canaccord. 2. Grocery Outlet (GO) initiated with an Outperform at Telsey Advisory and Cowen, a Buy at Jefferies, an Equal Weight at Morgan Stanley, as well as a Neutral at Goldman Sachs, BofA/Merrill, and Guggenheim. 3. Atreca (BCEL) initiated with an Outperform at Evercore ISI and Cowen, as well as a Buy at Stifel. 4. Aqua America (WTR) initiated with a Buy at BofA/Merrill. 5. Anaplan (PLAN) initiated with an Outperform at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/15/19
GUGG
07/15/19
INITIATION
GUGG
Neutral
Grocery Outlet initiated with a Neutral at Guggenheim
Prior to the open, Guggenheim analyst John Heinbockel initiated Grocery Outlet with a Neutral rating, stating that he believes the company is well positioned for 5-10 years of sales growth greater than 10% and deserves a premium valuation. However, with the shares up 55% since the IPO, he thinks the growth potential is reflected in the current valuation.
08/14/19
COWN
08/14/19
NO CHANGE
Target $48
COWN
Outperform
Grocery Outlet price target raised to $48 from $42 at Cowen
Cowen analyst Oliver Chen raised his price target on Grocery Outlet to $48 from $42 following Q2 results. The analyst said Grocery Outlet's off-price grocery model represents a compelling combination of high quality, national branded products at deep discounts. He is excited by its marketing and shopper engagement strategies as well as operational initiatives. Chen reiterated his Outperform rating on Grocery Outlet shares.
RDS.B Royal Dutch Shell
$55.56

0.46 (0.83%)

08/31/18
08/31/18
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. BP (BP) and Royal Dutch Shell (RDS.A) were upgraded to Hold from Underperform at Santander. 2. Dollar Tree (DLTR) downgraded to Market Perform from Outperform at Telsey Advisory. 3. Electronic Arts (EA) and Activision Blizzard (ATVI) were downgraded to Neutral from Buy at BofA/Merrill. 4. Gain Capital (GCAP) initiated with a Neutral at JPMorgan. 5. Avaya (AVYA) initiated with a Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/30/19
SOCG
05/30/19
UPGRADE
SOCG
Buy
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
05/13/19
05/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Royal Dutch Shell (RDS.A, RDS.B) upgraded to Buy from Hold at Deutsche Bank and HSBC. 2. KB Home (KBH) upgraded to Overweight from Equal Weight at Barclays with analyst Matthew Bouley saying his firm's spring agent survey confirmed that housing fundamentals have improved and stabilized. 3. Becton Dickinson (BDX) upgraded to Overweight from Equal Weight at Barclays with analyst Kristen Stewart saying the pullback in the shares since the FDA update on drug-coated balloons on March 15, coupled with the resetting of expectations following the company's Q2 results, provides an opportunity for investors. 4. Merck (MRK) upgraded to Overweight from Neutral at Atlantic Equities. 5. Bausch Health (BHC) upgraded to Neutral from Underweight at JPMorgan with analyst Chris Schott saying while a number of challenges remain in the story given the company's high leverage and controversial Xifaxan loss of exclusivity, its EBITDA is "clearly stabilizing and should begin to grow from here." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/02/19
BTIG
04/02/19
NO CHANGE
Target $225
BTIG
Buy
Wex price target raised to $225 from $198 at BTIG
BTIG analyst Mark Palmer reiterated a Buy rating on Wex (WEX) and raised his price target to $225 from $198, saying he believes the company is well positioned to deliver on the better-than-expected guidance for 2019 revenue growth that management provided on March 20 due in large part to the conversions of the Chevron (CVX) and Shell (RDS.A) fleet fuel card portfolios and the integration of recent acquisitions including the Noventis electronic payment network and Discovery Benefits.
RDS.A Royal Dutch Shell
$55.55

0.47 (0.85%)

06/14/19
MSCO
06/14/19
NO CHANGE
MSCO
Morgan Stanley prefers Total over Shell, expects dividend yield spread to widen
Morgan Stanley analyst Martijn Rats noted that the dividend yield spread for Total (TOT) vs. Shell (RDS.A) of 20 basis points is the tightest since late 2014 and "sharply lower" than the 100 bps three-year average. He attributes the recent relative outperformance of Shell over Total shares to enthusiasm about the former's long-term free cash flow guidance at its capital markets day and investor concern about the latter's plans to buy a package of Mozambique, Ghana and Algeria assets from Occidental (OXY). However, Rats thinks the spread should widen again in Total's favor, given its stronger dividend growth, healthier balance sheet and better visibility on production growth, among other reasons. He maintains an Equal Weight rating on Shell shares and Overweight rating on Total.
07/03/19
EXAN
07/03/19
DOWNGRADE
EXAN
Neutral
Royal Dutch Shell downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas analyst James Evans downgraded Royal Dutch Shell to Neutral from Outperform.
08/02/19
BOFA
08/02/19
NO CHANGE
BOFA
Royal Dutch Shell added to the Europe 1 List at BofA/Merrill
BP BP
$36.27

0.22 (0.61%)

07/31/19
07/31/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BP (BP) upgraded to Buy from Hold at Jefferies with analyst Jason Gammel saying he sees multiple near-term catalysts for the shares, including a dividend raise and share buybacks. 2. U.S. Bancorp (USB) upgraded to Neutral from Underweight at JPMorgan with analyst Vivek Juneja saying better growth in some fee revenues should partly offset the company's net interest margin pressure. 3. National Oilwell (NOV) upgraded to Buy from Neutral at Citi and to Neutral from Sell at Seaport Global. 4. Electronic Arts (EA) upgraded to Outperform from Market Perform at Cowen with analyst Douglas Creutz citing its 20% discount valuation to peers, strong Q1 results, readings from its Ordometer on its new Star Wars game, and upbeat management commentary. 5. Expedia (EXPE) upgraded to Buy from Hold at Argus with analyst John Staszak saying the trend of online travel bookings should continue to benefit the company's Expedia.com, Hotels.com, Orbitz, and Vrbo brands. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/19
JEFF
07/31/19
UPGRADE
Target $48.6
JEFF
Buy
BP upgraded to Buy from Hold at Jefferies
Jefferies analyst Jason Gammel upgraded BP to Buy from Hold and raised his price target for the shares to $48.60 from $46.30. The analyst sees multiple near-term catalysts for the shares, including a dividend raise and share buybacks. The stock's recent underperformance brings an attractive valuation, Gammel tells investors in a research note.
07/10/19
07/10/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Neutral from Buy at UBS with analyst Steven Fisher saying that after a "sharp" rebound from a weak May, the stock now balances the risks of near-term caution and the potential pick-up in 2020. 2. Universal Display (OLED) downgraded to Perform from Outperform at Oppenheimer with analyst Andrew Uerkwitz citing valuation. 3. Parker-Hannifin (PH) and Agco (AGCO) were downgraded to Neutral from Overweight at JPMorgan. 4. BP (BP) downgraded to Neutral from Outperform at Credit Suisse with analyst Thomas Adolff saying he now prefers shares of Total (TOT) as he believes they are trading at a cheaper valuation than BP. 5. Citizens Financial (CFG) downgraded to Neutral from Buy at UBS with analyst Saul Martinez saying the bank's "limited fee generation" and declining ROA make it vulnerable in a more challenging interest rate and credit environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/19
FBCO
07/10/19
DOWNGRADE
FBCO
Neutral
BP downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Thomas Adolff downgraded BP (BP) to Neutral from Outperform and lowered his price target for the shares to 605p from 640p. The analyst now prefers shares of Total (TOT) as he believes they are trading at a cheaper valuation than BP.
XOM Exxon Mobil
$68.30

1.06 (1.58%)

07/18/19
07/18/19
DOWNGRADE
Target $90

Sector Perform
Exxon Mobil downgraded to Sector Perform at RBC Capital on premium valuation
As previously reported, RBC Capital analyst Biraj Borkhataria downgraded Exxon Mobil to Sector Perform and lowered his price target to $90 from $100. The analyst is positive on the company's "counter-cyclical" strategy and longer term potential, but believes that it is faced with greater macro headwinds in Chemicals, refining & LNG sectors. Borkhataria further states that Exxon Mobil stock now trades at a significant premium on Enterprise Value to Debt-adjusted cash flow multiple basis relative to its key peers.
08/06/19
DZBN
08/06/19
UPGRADE
Target $70
DZBN
Hold
Exxon Mobil upgraded to Hold from Sell at DZ Bank
DZ Bank analyst Werner Eisenmann upgraded Exxon Mobil to Hold from Sell while lowering his price target for the shares to $70 from $72.
08/06/19
DZBN
08/06/19
UPGRADE
DZBN
Hold
Exxon Mobil upgraded to Hold from Sell at DZ Bank
07/18/19
07/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) and Skyworks (SWKS) downgraded to Equal Weight from Overweight at Barclays. 2. AMD (AMD) downgraded to Neutral from Buy at Mizuho with analyst Vijay Rakesh saying he continues to like AMD given its "solid" Ryzen/Rome portfolio and new product ramps, but he's downgrading the shares after a "stellar" 80% rally year-to-date. 3. BrightView (BV) downgraded to Neutral from Overweight at JPMorgan with analyst Judah Sokel saying he remains positive on the company's longer term potential, but he sees risk to estimates and prefers moving to the sidelines after the stock's year-to-date run of 75%. 4. MGM Resorts (MGM) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Thomas Allen saying he is concerned that Vegas, Macau, and its U.S. regional properties are all going to come in below his prior expectations. 5. Exxon Mobil (XOM) and Vermilion Energy (VET) downgraded to Sector Perform from Outperform at RBC Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MYGN Myriad Genetics
$25.36

2.14 (9.22%)

08/14/19
LEHM
08/14/19
DOWNGRADE
Target $25
LEHM
Underweight
Myriad Genetics downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Jack Meehan downgraded Myriad Genetics to Underweight from Equal Weight after the company disclosed that it is in discussion with the FDA to make changes to the GeneSight test report, which he thinks could compromise the test's value proposition. While Myriad would not comment further on what changes it would need to make, the analyst believes the primary concern raised by the FDA may be around specific medication recommendations for patients with depression. Meehan also lowered his price target on the shares to $25 from $40.
08/14/19
08/14/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Avedro (AVDR) downgraded to Neutral from Overweight at JPMorgan with analyst Robbie Marcus saying another suitor emerging to compete with Glaukos's (GKOS) buyout offer is unlikely. 2. Myriad Genetics (MYGN) downgraded to Neutral from Overweight at Piper Jaffray with analyst William Quirk saying the company reported "disappointing" fiscal Q4 results with revenue, adjusted earnings and FY20 guidance well below consensus. 3. Pattern Energy (PEGI) downgraded to Market Perform from Outperform at Wells Fargo with analyst Neil Kalton saying after the company confirmed it has drawn interest from third parties, the analyst believes Pattern's current valuation reflects some amount of a takeout premium. 4. Advance Auto Parts (AAP) downgraded to Neutral from Buy at Guggenheim with analyst Ali Faghri citing the company's weaker than expected Q2 results and sees risk to its fiscal 2019 guidance. 5. Equity Commonwealth (EQC) downgraded to Market Perform at JMP Securities with analyst Mitch Germain citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/14/19
DBAB
08/14/19
NO CHANGE
Target $35
DBAB
Hold
Myriad Genetics price target lowered to $35 from $45 at Deutsche Bank
Deutsche Bank analyst Matt O'Connor lowered his price target for Myriad Genetics to $35 from $45 following last night's "tough" quarter. The analyst keeps a Hold rating on the shares saying he'd be more constructive on greater conviction in Myriad's efforts outside of hereditary cancer testing and/or greater volume growth in hereditary cancer testing.
08/14/19
JPMS
08/14/19
NO CHANGE
Target $27
JPMS
Underweight
Myriad Genetics reported another disappointing quarter, says JPMorgan
Myriad Genetics reported another disappointing quarter as most products fell short of expectations, JPMorgan analyst Tycho Peterson tells investors in a research note. While the company continues to make incremental progress on guideline and reimbursement expansion for a number of products, the timing and magnitude of revenue upside remains uncertain, adds the analyst. Peterson sees more downside risk for shares at current levels and maintains an Underweight rating on Myriad Genetics with a $27 price target.

TODAY'S FREE FLY STORIES

01:40
09/16/19
09/16
01:40
09/16/19
01:40
General news
Asian Market Wrap: »

Asian Market Wrap:…

BAC

Bank of America

$30.12

0.44 (1.48%)

, TPR

Tapestry

$25.16

-0.43 (-1.68%)

19:46
09/15/19
09/15
19:46
09/15/19
19:46
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

BAC

Bank of America

$30.12

0.44 (1.48%)

TPR

Tapestry

$25.16

-0.43 (-1.68%)

T

AT&T

$37.90

-0.46 (-1.20%)

UHAL

Amerco

$379.63

4.21 (1.12%)

GM

General Motors

$38.83

-0.22 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 16

    Oct

  • 23

    Oct

GM

General Motors

$38.83

-0.22 (-0.56%)

19:23
09/15/19
09/15
19:23
09/15/19
19:23
Hot Stocks
President Trump urges General Motors, UAW to resolve contract dispute »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBCI

Glacier Bancorp

$41.37

0.43 (1.05%)

17:04
09/15/19
09/15
17:04
09/15/19
17:04
Conference/Events
Glacier Bancorp management to meet with Janney Montgomery Scott »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 06

    Nov

16:55
09/15/19
09/15
16:55
09/15/19
16:55
Conference/Events
SunTrust retail/consumer goods analysts to hold a dinner meeting »

Retail/Consumer Goods…

16:55
09/15/19
09/15
16:55
09/15/19
16:55
Conference/Events
SunTrust retail analyst team to hold a dinner meeting »

The Retail/Consumer Goods…

T

AT&T

$37.90

-0.46 (-1.20%)

, CMCSA

Comcast

$46.89

-0.08 (-0.17%)

16:54
09/15/19
09/15
16:54
09/15/19
16:54
On The Fly
Box Office Battle: 'It: Chapter Two' wins weekend again with $40.8M »

"Box Office Battle" is…

T

AT&T

$37.90

-0.46 (-1.20%)

CMCSA

Comcast

$46.89

-0.08 (-0.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$60.37

0.06 (0.10%)

LGF.A

Lionsgate

$11.15

-0.065 (-0.58%)

LGF.B

Lionsgate

$10.44

-0.1 (-0.95%)

DIS

Disney

$138.00

0.44 (0.32%)

VIAB

Viacom

$26.05

0.02 (0.08%)

VIA

Viacom

$28.01

-0.1 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

BA

Boeing

$379.87

4.3 (1.14%)

16:34
09/15/19
09/15
16:34
09/15/19
16:34
Periodicals
Boeing board to call for safety changes following 737 Max crashes, NYTimes says »

For the past five months,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FB

Facebook

$186.97

-0.42 (-0.22%)

16:25
09/15/19
09/15
16:25
09/15/19
16:25
Periodicals
Regulators to question Facebook's Libra amid EU concerns, FT reports »

Facebook will be quizzed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

AAPL

Apple

$218.71

-4.4 (-1.97%)

16:22
09/15/19
09/15
16:22
09/15/19
16:22
Periodicals
Apple TV+ premieres with period drama at Tribeca Festival, Reuters reports »

Apple TV+ premiered its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$42.01

-0.77 (-1.80%)

, BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

16:19
09/15/19
09/15
16:19
09/15/19
16:19
Periodicals
New York bans flavored e-cigarettes, Reuters reports »

New York Governor Andrew…

MO

Altria Group

$42.01

-0.77 (-1.80%)

BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$73.01

-1.89 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SPY

SPDR S&P 500 ETF Trust

$300.98

-0.29 (-0.10%)

, SPX

S&P 500

$0.00

(0.00%)

15:52
09/15/19
09/15
15:52
09/15/19
15:52
Periodicals
Spare oil capacity in U.S. hands after Saudi outage, Reuters says »

An attack on Saudi oil…

SPY

SPDR S&P 500 ETF Trust

$300.98

-0.29 (-0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENRFF

Enerflex

$0.00

(0.00%)

15:52
09/15/19
09/15
15:52
09/15/19
15:52
Conference/Events
Enerflex management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SNMSF

Spin Master

$0.00

(0.00%)

15:50
09/15/19
09/15
15:50
09/15/19
15:50
Conference/Events
Spin Master management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 12

    Nov

WFTBF

West Fraser Timber

$0.00

(0.00%)

15:48
09/15/19
09/15
15:48
09/15/19
15:48
Conference/Events
West Fraser Timber management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

GM

General Motors

$38.83

-0.22 (-0.56%)

15:41
09/15/19
09/15
15:41
09/15/19
15:41
Periodicals
UAW calls strike against GM amid financial crisis, CNBC reports »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$14.99

0.805 (5.68%)

15:34
09/15/19
09/15
15:34
09/15/19
15:34
Hot Stocks
Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301 »

Kodiak Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

LHX

L3Harris Technologies

$207.62

-1.88 (-0.90%)

, ESLT

Elbit Systems

$157.40

-0.2 (-0.13%)

15:30
09/15/19
09/15
15:30
09/15/19
15:30
Hot Stocks
L3Harris Technologies completes sale of Harris Night Vision business »

L3Harris Technologies…

LHX

L3Harris Technologies

$207.62

-1.88 (-0.90%)

ESLT

Elbit Systems

$157.40

-0.2 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, BJ

BJ's Wholesale

$27.45

-0.02 (-0.07%)

12:56
09/15/19
09/15
12:56
09/15/19
12:56
Conference/Events
Shoptalk to hold a conference »

Grocery Shop to be held…

BAYRY

Bayer

$0.00

(0.00%)

BJ

BJ's Wholesale

$27.45

-0.02 (-0.07%)

BMBOY

Grupo Bimbo

$0.00

(0.00%)

FB

Facebook

$186.97

-0.42 (-0.22%)

FORR

Forrester

$36.33

0.38 (1.06%)

HAIN

Hain Celestial

$21.97

0.25 (1.15%)

HSY

Hershey

$148.68

-2.445 (-1.62%)

IBM

IBM

$143.59

-0.01 (-0.01%)

K

Kellogg

$63.36

-0.33 (-0.52%)

MDLZ

Mondelez

$54.08

-0.7 (-1.28%)

NLSN

Nielsen

$22.45

-0.06 (-0.27%)

PG

Procter & Gamble

$122.11

-0.68 (-0.55%)

PJC

Piper Jaffray

$78.23

-0.39 (-0.50%)

REV

Revlon

$19.86

0.02 (0.10%)

SJM

J.M. Smucker

$106.51

0.72 (0.68%)

TGT

Target

$108.01

-0.92 (-0.84%)

TSN

Tyson Foods

$85.19

1.71 (2.05%)

UL

Unilever; also tag UN

$61.15

-0.52 (-0.84%)

WMT

Walmart

$117.40

0.42 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 15

    Sep

  • 17

    Sep

  • 19

    Sep

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 08

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

NVCR

Novocure

$79.29

-0.92 (-1.15%)

, RHHBY

Roche

$0.00

(0.00%)

12:54
09/15/19
09/15
12:54
09/15/19
12:54
Conference/Events
American Society for Radiation Oncology to hold annual meeting »

2019 ASTRO Annual Meeting…

NVCR

Novocure

$79.29

-0.92 (-1.15%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$43.72

-0.11 (-0.25%)

SIEGY

Siemens

$0.00

(0.00%)

TDY

Teledyne

$315.15

2.75 (0.88%)

VAR

Varian Medical

$117.39

-2.19 (-1.83%)

HTHIY

Hitachi

$0.00

(0.00%)

GHDX

Genomic Health

$71.69

-1.02 (-1.40%)

ESALY

Eisai

$0.00

(0.00%)

EKTAY

Elekta

$0.00

(0.00%)

BMY

Bristol-Myers

$49.40

-0.22 (-0.44%)

BSX

Boston Scientific

$41.81

-0.42 (-0.99%)

BAYRY

Bayer

$0.00

(0.00%)

AZN

AstraZeneca

$42.76

-0.14 (-0.33%)

ARAY

Accuray

$3.03

(0.00%)

MRK

Merck

$82.61

0.38 (0.46%)

MDT

Medtronic

$109.63

-0.77 (-0.70%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

HOLX

Hologic

$49.72

-0.09 (-0.18%)

ISR

IsoRay

$0.32

-0.0059 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 15

    Sep

  • 16

    Sep

  • 16

    Sep

  • 16

    Sep

  • 16

    Sep

  • 18

    Sep

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 23

    Oct

  • 29

    Oct

  • 31

    Oct

  • 04

    Nov

  • 13

    Nov

12:50
09/15/19
09/15
12:50
09/15/19
12:50
Conference/Events
SunTrust retail analyst team to hold a dinner meeting »

The Retail/Consumer Goods…

NET

Cloudflare

$17.96

(0.00%)

, AMZN

Amazon.com

$1,837.49

-6 (-0.33%)

07:40
09/15/19
09/15
07:40
09/15/19
07:40
On The Fly
Opening Day: Cloudflare jumps in market debut »

Shares of Cloudflare…

NET

Cloudflare

$17.96

(0.00%)

AMZN

Amazon.com

$1,837.49

-6 (-0.33%)

MSFT

Microsoft

$137.21

-0.33 (-0.24%)

STSA

Satsuma Pharmaceuticals

$16.61

(0.00%)

SWTX

SpringsWorks Therapeutics

$22.75

(0.00%)

SDC

SmileDirectClub

$18.68

1.8 (10.66%)

TXG

10x Genomics

$53.80

0.85 (1.61%)

PTON

Peloton

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

NVST

Envista

$0.00

(0.00%)

XGN

Exagen

$0.00

(0.00%)

DDOG

Datadog

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

NDAQ

Nasdaq

$99.51

0.5 (0.51%)

DHR

Danaher

$141.02

-0.84 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 17

    Sep

  • 27

    Oct

  • 07

    Nov

  • 18

    Sep

  • 19

    Sep

  • 26

    Sep

04:55
09/15/19
09/15
04:55
09/15/19
04:55
Conference/Events
SunTrust retail/consumer goods analysts to hold a dinner meeting »

Retail/Consumer Goods…

ABT

Abbott

$84.25

-0.96 (-1.13%)

, ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

13:22
09/14/19
09/14
13:22
09/14/19
13:22
Conference/Events
William Blair diagnostic products/med tech analyst to hold a group luncheon »

Diagnostic Products &…

ABT

Abbott

$84.25

-0.96 (-1.13%)

ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

BDX

Becton Dickinson

$260.68

-1.41 (-0.54%)

COO

Cooper Companies

$301.95

-3 (-0.98%)

EXAS

Exact Sciences

$106.72

-1.99 (-1.83%)

GH

Guardant Health

$77.54

0.49 (0.64%)

NEO

NeoGenomics

$21.34

-1.22 (-5.41%)

LMNX

Luminex

$22.62

0.1 (0.44%)

HAE

Haemonetics

$125.55

-0.31 (-0.25%)

STAA

STAAR Surgical

$29.21

0.415 (1.44%)

QGEN

Qiagen

$33.97

-0.105 (-0.31%)

NVTA

Invitae

$21.70

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 13

    Nov

  • 05

    Dec

CRTO

Criteo

, TWTR

Twitter

13:19
09/14/19
09/14
13:19
09/14/19
13:19
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Technology & Internet…

CRTO

Criteo

TWTR

Twitter

SNAP

Snap

GOOGL

Alphabet Class A

FB

Facebook

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.